Pin Wang, Ph.D.
Affiliations: | 2004 | California Institute of Technology, Pasadena, CA |
Area:
artificial proteinsGoogle:
"Pin Wang"Mean distance: 8.74
Parents
Sign in to add mentor| David A. Tirrell | grad student | 2004 | Caltech | |
| (Expanding the biosynthetic capacity of the aminoacyl -tRNA synthetases.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ando Y, Siegler EL, Ta HP, et al. (2019) Evaluating CAR-T Cell Therapy in a Hypoxic 3D Tumor Model. Advanced Healthcare Materials. e1900001 |
| Qu Y, Siegler E, Cheng C, et al. (2019) Engineering CAR-expressing natural killer cells with cytokine signaling and synthetic switch for an off-the-shelf cell-based cancer immunotherapy Mrs Communications. 9: 433-440 |
| Siriwon N, Kim YJ, Siegler EL, et al. (2018) CAR-T Cells Surface-Engineered with Drug-Encapsulated Nanoparticles Can Ameliorate Intratumoral T Cell Hypofunction. Cancer Immunology Research |
| Liu Y, Zhu B, Jia Q, et al. (2018) Durable clinical responses observed from non-Hodgkin lymphoma patients treated with autologous CAR-T cells targeting CD19. Journal of Clinical Oncology. 36: 3045-3045 |
| Liu Y, Chen Z, Fang H, et al. (2018) Durable Remission Achieved from Bcma-Directed CAR-T Therapy Against Relapsed or Refractory Multiple Myeloma Blood. 132: 956-956 |
| Siegler EL, Wang P. (2018) Abstract A59: Expression of membrane-bound IL-15/IL-15Rα complex in chimeric antigen receptor-engineered natural killer cells for enhanced efficacy against solid tumors Cancer Immunology Research. 6 |
| Rohrs JA, Zheng D, Graham NA, et al. (2018) Abstract A53: Mechanistic model predicts effects of altering CD3ζ immuno-tyrosine activating motif (ITAM) structure in chimeric antigen receptor- (CAR-) engineered T cells Cancer Immunology Research. 6 |
| Rohrs JA, Zheng D, Graham NA, et al. (2018) Abstract NG01: Effects of altering receptor structure in CAR T cells: Predictions from an experimentally-validated systems biology model Cancer Research. 78 |
| Siegler EL, Kim YJ, Chen X, et al. (2017) Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Bryson PD, Han X, Truong N, et al. (2017) Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growth. Vaccine |